Christopher S Henney Prothena Corp Public LTD CO (PRTA) insider trading activity

Christopher S Henney is Director of PROTHENA CORP PUBLIC LTD CO. Currently has a direct ownership of 0 shares of PRTA, which is worth approximately $0. The most recent transaction as insider was on Jul 14, 2021, when has been sold 11,108 shares (Ordinary Shares, par value $0.01 per share) at a price of $55.72 per share, resulting in proceeds of $618,938. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

CHRISTOPHER S HENNEY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 14 2021	SELL Open market or private sale	$618,938 $55.72 p/Share	11,108 Reduced 100.0%	0 Ordinary Shares, par v...
Jul 14 2021	BUY Exercise of conversion of derivative security	$125,854 $11.33 p/Share	11,108 Added 50.0%	11,108 Ordinary Shares, par v...
Jul 12 2021	SELL Open market or private sale	$1,376,418 $57.61 p/Share	23,892 Reduced 100.0%	0 Ordinary Shares, par v...
Jul 12 2021	BUY Exercise of conversion of derivative security	$245,610 $10.28 p/Share	23,892 Added 78.89%	6,392 Ordinary Shares, par v...
Jun 25 2021	SELL Open market or private sale	$577,800 $48.15 p/Share	12,000 Reduced 100.0%	0 Ordinary Shares, par v...
Jun 25 2021	BUY Exercise of conversion of derivative security	$197,160 $16.43 p/Share	12,000 Added 50.0%	12,000 Ordinary Shares, par v...
Sep 28 2017	SELL Open market or private sale	$63,000 $70.0 p/Share	900 Reduced 100.0%	0 Ordinary Shares, par v...
Sep 28 2017	BUY Exercise of conversion of derivative security	$5,985 $6.65 p/Share	900 Added 50.0%	900 Ordinary Shares, par v...
Jul 17 2017	SELL Open market or private sale	$330,650 $66.13 p/Share	5,000 Reduced 100.0%	0 Ordinary Shares, par v...
Jul 17 2017	BUY Exercise of conversion of derivative security	$33,250 $6.65 p/Share	5,000 Added 50.0%	5,000 Ordinary Shares, par v...
Feb 27 2017	SELL Open market or private sale	$342,331 $57.16 p/Share	5,989 Reduced 100.0%	0 Ordinary Shares, par v...
Feb 27 2017	BUY Exercise of conversion of derivative security	$39,827 $6.65 p/Share	5,989 Added 50.0%	5,989 Ordinary Shares, par v...
Feb 17 2017	SELL Open market or private sale	$228,868 $57.06 p/Share	4,011 Reduced 100.0%	0 Ordinary Shares, par v...
Feb 17 2017	BUY Exercise of conversion of derivative security	$26,673 $6.65 p/Share	4,011 Added 50.0%	4,011 Ordinary Shares, par v...
Nov 27 2015	SELL Open market or private sale	$375,000 $75.0 p/Share	5,000 Reduced 100.0%	0 Ordinary Shares, par v...
Nov 27 2015	BUY Exercise of conversion of derivative security	$33,250 $6.65 p/Share	5,000 Added 50.0%	5,000 Ordinary Shares, par v...
Oct 29 2015	SELL Open market or private sale	$275,000 $55.0 p/Share	5,000 Reduced 100.0%	0 Ordinary Shares, par v...
Oct 29 2015	BUY Exercise of conversion of derivative security	$33,250 $6.65 p/Share	5,000 Added 50.0%	5,000 Ordinary Shares, par v...
Aug 07 2015	SELL Open market or private sale	$632,100 $63.21 p/Share	10,000 Reduced 100.0%	0 Ordinary Shares, par v...
Aug 07 2015	BUY Exercise of conversion of derivative security	$64,100 $6.41 p/Share	10,000 Added 50.0%	10,000 Ordinary Shares, par v...

Also insider at

CYCC

Cyclacel Pharmaceuticals, Inc. Healthcare

Director

CSH